Launch of the Cleveland Clinic CHIP Clinic: Applying Genomic Discovery to Cardiology
Krishna Aragam, Director of Cardiovascular Genomics at Cleveland Clinic, reposted Ohad Oren’s post on LinkedIn:
“Great to see the launch of the Cleveland Clinic Clonal Hematopoiesis of Indeterminate Potential (CHIP) Cardiology Clinic, a new frontier for applying genomic discoveries to cardiovascular medicine.
CHIP represents a powerful example of how genomic variation — in this case somatic (acquired later in life) rather than germline (inherited at birth) — can inform personalized cardiovascular risk and management.
Looking forward to working with Ohad Oren, MD, MPH and the team to advance precision cardiovascular care guided by genomic insights at the Cleveland Clinic Heart, Vascular and Thoracic Institute.”
Quoting Ohad Oren’s post:
“Launching the Cleveland Clinic CHIP Cardiology Clinic, an exciting step toward integrating clonal hematopoiesis into cardiovascular care.
Excited to share my Circulation paper with Dr. Peter Libby, outlining our vision for the growth and development of CHIP Cardiology programs”
Title: Incorporating Management of Clonal Hematopoiesis of Indeterminate Potential Into Cardiovascular Practice
Authors: Ohad Oren, Peter Libby

Stay informed with Hemostasis Today.
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests
-
Aug 26, 2026, 17:46Bruno Pougault: The Hidden Burden of Hemostatic Disorders in Women
-
Aug 26, 2026, 17:39Charan Gubba: Adult ITP – A major shift in the 2026 ASH Guidelines
-
Aug 26, 2026, 17:38Stephan A Mayer: Early Imaging Reveals Higher Risk of Hematoma Expansion After ICH
-
Aug 26, 2026, 17:09Kemal Karaagac: NOACs May Offer Cognitive and Clinical Benefits in AF With Alzheimer’s Disease
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation